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Aim: The aim of the study was to determine the phosphorylated c-Jun content and reduced and oxidized glutathione (GSH/GSSG) 
ratio in gastric mucosa cells during the process of gastric cancer development in rats. Materials and Methods: Gastric carcinoge-
nesis was initiated in 80 white male rats by 10-week replacement of drinking water with 0.01% solution of N-methyl-N´-nitro-N-
nitrosoguanidine, at the same time they were redefined on diet containing 5% NaCl. Then the animals were fed with standard vi-
varium diet till the end of 24th week. The gastric mucosa cells were examined at the end of 4th, 6th, 8th, 10th, 12th, 18th, and 24th weeks. 
Sandwich ELISA method was used to determine the content of phospho-c-Jun. The contents of GSH and GSSG were analyzed 
by spectrofluorymetric method with the use of orthophthalic aldehyde. Results: At the end of 6th, 8th, 10th weeks of MNNG and NaCl 
treatment the gastric mucosa cells were characterized by 4-, 6.3-, 1.9-fold higher content of phospho-c-Jun compared to the con-
trol, respectively, and 12, 18 and 24 weeks there was registered a stable increase of phospho-c-Jun content on the average at 3.6-fold 
compared to control values. Starting from 6th week of gastric cancer development an average decrease of GSH/GSSG was 3.4-fold 
compared with the control. Conclusion: During gastric carcinogenesis there was registered the decrease of GSH/GSSG ratio and 
increased level of phosphorylated c-Jun what points on MAP-kinase cascade activation in prooxidant conditions.
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Gastric cancer is the second leading cause of can-
cer deaths worldwide. Several factors are thought 
to play a role in gastric carcinogenesis, including 
diet, exogenous chemicals, intragastric synthesis 
of carcinogens, genetic factors, infectious agents and 
pathological conditions in the stomach (such as gastri-
tis) [1]. Smoked foods rich in nitrates, a high-salt diet, 
and Helicobacter pylori infection seem to be major 
environmental inducers of gastric cancer [2]. However, 
it remains unclear which molecular signals actually 
initiate the program of cell transformation.
Oxidative stress, nevertheless, appears to be an im-
portant factor in the induction of cancer [3, 4]. Reactive 
oxygen species (ROS) can directly produce single- 
or double-stranded DNA breaks, purine, pyrimidine, 
or deoxyribose modifications, and DNA cross-links. 
Persistent DNA damages can result in either arrest or in-
duction of transcription, induction of signal transduction 
pathways, replication errors, and genomic instability, 
which are all seen in carcinogenesis [5]. Cellular oxidative 
stress can modify intercellular communication, protein 
kinase activity, membrane structure and function, and 
gene expression, and may result in modulation of cell 
growth [3].
At the same time a vast number of cellular processes 
is affected by the redox state, in which glutathione has 
a pivotal role. The most prevalent non-protein thiol 
in mammalian cells and the most abundant low mole-
cular-weight peptide present in eukaryotic cells [6] — 
glutathione, exists in reduced (GSH) and disulfide/oxi-
dized (GSSG) forms (GSH being predominant). The re-
dox regulation affects numerous signalling pathways 
through protein phosphorylation and induces selectively 
a number of genes. Molecules activated in this way 
include transcription factor activator protein-1  (AP-1), 
responsible for the expression of a number of genes in-
cluding many cytokines, TGF-β and collagenase,  AP-2, 
c-Jun N-terminal kinase (JNK), protein kinase C and 
tyrosine kinase [7]. The overactivity of transcription fac-
tors that are activated directly by specific phosphoryla-
tion or that became activated following phosphorylation 
of other cellular proteins is an event in carcinogenesis 
that increases disregulation. Redox cycling of cysteinyl 
residues is one of se veral oxidant-dependent mecha-
nisms that regulate the activity of many transcription 
factors, such as AP-1 [8] and particularly c-Jun, 
a potent transcriptional regulator is involved in cellular 
proliferation control [9, 10].
The resident nuclear protein c-Jun is one of hun-
dreds of nuclear proteins that are being targets of serine 
proteinkinase cascades that are initiated in the cyto-
plasm and lead to phosphorylation and activation of this 
protein [11]. c-Jun is a major component of AP-1 and 
forms homodimers, or heterodimers with other Jun, 
Fos or ATF proteins [12]. Although the repertoire 
of AP-1 complexes varies between different cell types, 
c-Jun is a dominant component in many cells [13]. 
It is believed, that c-Jun is a critical promoter of cellular 
proliferation and dysregulated expression and activation 
of its oncogene are frequently observed in many tumor 
types [14] including gastric cancer [2]. But there are 
a lot of evidences that  c-Jun/AP-1 activation has been 
implicated in various, often opposing cellular respons-
es. Although there is a consi derable evidence that c-Jun 
activation can be a positive step in the events leading 
Submitted: May 21, 2014.
*Correspondence:  E-mail: maria.bulavka@gmail.com
 Fax: +38 (044) 521-35-98
Abbreviations used: AP-1 — activator protein-1; GSH — reduce gluta-
thione; GSSG — oxidized glutathione; JNK — c-Jun N-terminal kinase; 
MAP kinase — mitogen-activated protein kinase; MNNG — N-methyl-
N’-nitro-N-nitrosoguanidine; ROS — reactive oxygen species.
Exp Oncol 2014
36, 3, 191–195
192 Experimental Oncology 36, 191–195, 2014 (September)
a cell towards apoptosis, there are also many reports 
stating the opposite: that under certain circumstances 
c-Jun can inhibit apoptosis and promote proliferation 
or differentiation. It is clear that the effects of c-Jun 
on cellular responses depend strongly on the cell type 
and the context of other regulatory influences that the 
cell is receiving [15].
The aim of this study was to determine the changes 
in phosphorylated c-Jun content and the level of GSH/
GSSG ratio in gastric mucosa cells during the process 
of experimental gastric carcinogenesis using the 
N-methyl-N´-nitro-N-nitrosoguanidine (MNNG) medi-
ated gastric cancer model in rats.
MATERIALS AND METHODS
The experiments were conducted using white male 
rats (n = 80) with the initial weight of 100 ± 20 g.
Gastric carcinogenesis was initiated by 10-week re-
placement of drinking water by 0.01% solution of car-
cinogen MNNG while the rats were given the feed, 
containing sodium chloride (5% NaCl of dry weight). 
Then the animals were fed with standard vivarium diet 
till the end of the 24th week [16, 17]. The control group 
of animals was fed with the standard diet during the all 
experimental period. The samplings of experimental 
material were taken at the end of 4th, 6th, 8th, 10th, 12th, 
18th, and 24th weeks. The gastric cancer development 
was verified visually and histologically.
The gastric mucosa cells were isolated by the me-
thod, based on the enzymatic disaggregation of cells 
using pronase [18]. This method presupposed turning 
the mucosa of the isolated stomachs outward, deliga-
tion, filling them with the pronase solution (1 mg/ml), 
incubating (30 min, 37 °C) at intense stirring in the me-
dium, saturated with 95% O2 and 5% CO2, and harvest-
ing the disintegrated cells. To cytosol obtaining the 
isolated cells were homogenized on ice in teflon Potter-
El vehjem homogenizer. 0.01 M formic acid was added 
to the homogenate (1:1) for precipitation of proteins 
[19] and the mixture was centrifuged at 20 000 g for 
15 min (4 °C) at Sigma centrifuge (USA). Both GSSG 
and GSH contents were measured in the supernatant.
The GSH content was registered using ortho- 
phthalic aldehyde, the reaction of the latter with GSH 
resulted in the formation of highly fluorescent products. 
The final mixture for the analysis contained 100 μl of the 
supernatant, diluted tenfold with 0.1 M phosphate 
buffer with 5 mM EDTA (pH 8.0), 1.8 ml of phosphate-
EDTA buffer and 100 μl of ortho-phthalic aldehyde 
(1 mg/ml in methanol). The fluorescence intensity was 
measured at 420 nm with the activation of 350 nm af-
ter 15 min incubation at room temperature. The GSH 
concentration was expressed as nmol/mg protein. 
The GSSG content was determined similarly to fluo-
rometric method of GSH estimation with previous 
incubation of supernatant with 0.04 М N-ethylmaleimid 
and following substitution 0.1 M phosphate buffer with 
5 mM EDTA (pH 8.0) for 0.1 N NaOH (рН = 12) [19].
The phospho-c-Jun content was revealed in gastric 
mucosa cell lysate prepared with the use of Cell Lysis 
Buffer (Cell Signaling Technology, USA). The phospho-
c-Jun content was measured by Sandwich ELISA 
method using the assay kit PathScan Phospho-c-Jun 
(Ser63) (Cell Signaling Technology, USA) and repre-
sented in conventional unit of absorbancy (λ = 450 nm) 
on mg of the protein.
The protein concentration was registered by Brad-
ford’s method [20].
The experimental data were processed by the com-
mon methods of the variance analysis with 7 repeats. 
The reliability of discrepancies between two samplings 
was determined using Student’s criterion. The results 
are presented in the values of the arithmetic mean and 
standard error mean, M ± S.E.m [21].
The investigations were carried out in accordance 
with the main requirements to keeping and working 
with laboratory animals and to the rules of the Eu-
ropean Convention for the Protection of Vertebrate 
Animals used for Experimental and other Scientific 
Purposes (Strasbourg, 1986) as well as with the ethic 
norms specified in the Ukrainian legislation.
RESULTS AND DISCUSSION
Histological investigations were conducted for es-
tablishment of gastric cancer progression and estima-
tion of gastric mucosa state under the gastric cancer 
development. The inflammation signs, the extension 
and plethora of vessels, the desquamation of epithe-
lial cells, and the increase in the production of mucus 
at the end of the 6th week of experimental gastric carci-
nogenesis were shown [22]. After the effect of MNNG 
for 8 weeks the gastric mucosa de monstrated the atro-
phic changes. Metaplastic modifications, sites with 
hyperplastic impairments, and some cells with atypia 
were observed after 10 weeks of MNNG treatment. 
Some animals had adenomas and one adenocarci-
noma at the end of the 12th week of the experiment. 
Such neoplasms were visualized in stomach pyloric 
region in 70% rats at the end of 18th week of the ex-
perimental gastric carcinogenesis.
The role of c-Jun in cellular transformation has been 
defined previously in rodent and avian model systems. 
Deregulated expression of c-Jun can lead to malignant 
transformation of immortalized rat fibroblasts while 
transformation of primary rat embryo cells required co-
expression of an activated c-Ha-ras. In chicken embryo 
fibroblasts, c-Jun can induce cellular transformation 
by itself. Stable expression of a trans-activation sup-
pressing deletion mutant of c-jun in malignant mouse 
epidermal cell lines inhibited tumor formation in nude 
mice. In human cancer, the role of c-jun/AP-1 is less 
clear. Increased constitutive levels of c-jun and c-fos 
mRNA and AP-1 levels have been reported for drug-
resistant cells (such as etoposide resistant human 
leukemia K562 cells) compared to drug-sensitive pa-
rental lines. In the human breast adenocarcinoma cell 
line MCF-7, mitogenic stimulation by insulin or other 
insulin-like growth factors leads to increased c-jun 
or c-fos expression and AP-1 activity. In a study of non-
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small cell lung primary and metastatic tumors, c-Jun 
is found to be overexpressed in 31% of the cases [23].
However, c-Jun role and even its activated form 
phospho-c-Jun in gastric tumorigenesis remain un-
known. The submitted studies showed the control 
reference of phospho-c-Jun content at the end of 4th 
week of MNNG and NaCl consumption (Fig. 1) and 
morpho-histological changes at the same timepoint 
weren’t observed. The gastric mucosa cells were 
characterized by increased content of phospho-c-Jun 
at 4.0- and 6.3-fold over the control at the end of 6th 
and 8th weeks, respectively, of the MNNG and NaCl 
treatment. Also it was established that the MNNG 
and NaCl treatment for 10 weeks caused 1.9-fold 
increase in phospho-c-Jun content compared 
to the control. At the terminal stages (12th, 18th and 
24th weeks) of the gastric carcinogenesis study, that 
were characterized by adenocarcinomas in pyloric 
region, there was a stable increase of phospho-c-Jun 
content on the average at 3.6-fold in comparison with 
reference values.
The odtained experimental data of high phospho-
c-Jun content in gastric mucosa cells are in agreement 
with the results of the immunohistochemical analysis 
that revealed activation of JNK in human gastric cancer 
tissue. Also mice lacking JNK1, a major JNK isozyme, 
exhibited a marked decrease in gastric carcinogenesis 
induced by N-methyl-N-nitrosourea relative to their 
wild-type counterparts [2].
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Fig. 1. The phospho-c-Jun content in gastric mucosa cells un-
der gastric cancer development. *The difference is significant 
as compared to appropriate control (p < 0.05)
c-Jun is unique in its ability to positively regulate 
cell proliferation through repression of tumor sup-
pressor gene expression and function, and induction 
of cyclin D1 transcription [9]. c-Jun, a specific target 
of JNK [13], is phosphorylated at serines 63 and 
73 and threonines 91 and 93 within the transactivation 
domain [12]. Phosphorylation is the most important 
regulation of c-Jun and influences the activity of a pro-
tein by affecting the DNA-binding, stability, ability 
to interact with other proteins, and transactivation po-
tential [12]. This phosphorylation event was suggested 
to stimulate c-Jun transcriptional activity, leading to the 
autoregulatory induction of c-jun, and, consequently, 
other genes [24]. JNK-mediated phosphorylation 
of Ser63/73 was demonstrated to inhibit both ubiq-
uitination and degradation of c-Jun, leading to accu-
mulation of the protein and increased transcriptional 
activity. Phosphorylation of c-Jun stimulates transcrip-
tional activity by recruiting co-activator CREB-binding 
protein (CBP). CBP binds to the  N-terminal activation 
domain of c-Jun and connects the phosphorylated ac-
tivation domain to the basal transcriptional machinery.
Also c-Jun is phosphorylated at threonines 
231 and 239 and serines 243 and 249 located proximal 
to the DNA-binding domain in the C-terminus. These 
sites are dephosphorylated during c-Jun activation 
and represent inhibitory phosphate groups. Activa-
tion of c-Jun requires phosphorylation of serines 
63 and 73, as well as dephosphorylation of at least 
one of the  C-terminal sites [12]. JNKs are also sub-
ject to inactivation. This is mediated by a specialized 
group of phosphatases, called MAP Kinase Phospha-
tases [13].
Thus, the growth of the phosphorylated form 
of c-Jun content from 6th to 24th weeks of gastric 
cancer development was caused by its high expres-
sion, amplification of JNK-mediated phosphorylation 
or inactivation of the phoshpatases. Like other Protein 
Tyrosine Phosphatases, MAP Kinase Phosphatases 
contain a highly reactive cysteine that mediates their 
inactivation, offering a way to regulate MAP kinase 
activity in response to production of ROS or exposure 
to thiol-reactive compounds [13]. Besides, it has 
been reported that N-nitroso compounds, which are 
important gastric carcinogens and potent inducers 
of cellular stress, leading to chromosomal aberrations, 
point mutations, cell death, and DNA damage, induce 
a specific cellular response program, which includes 
the activation of JNKs [25]. ROS-dependent redox 
cycling of cysteinyl thiols is also critical for the es-
tablishment of the protein-protein and protein-DNA 
interactions that determine many aspects of a signal 
transduction pathway. There is growing evidence that 
the reversible formation of mixed disulfides between 
GSH and low-pKa cysteinyl residues of proteins 
( S-glutathionylation) is an important mechanism for 
dynamic, posttranslational regulation of a variety 
of regulatory, structural, and metabolic proteins, and 
for the regulation of signaling and metabolic pathways 
in intact cell systems [26]. The c-Jun protein belongs 
to such molecules whose activity depends on the glu-
tathione redox state.
The major marker of intracellular redox state 
is the ratio of GSH to glutathione disulfide so it has 
been suggested to regulate the activation of redox-
sensitive transcriptional factors [27].
The 4th week of MNNG-stimulated carcinoge nesis 
was characterised by increased GSH/GSSG ratio 
(Table). Such change was the consequence of more 
than twofold increased GSH content compared 
with the control values while the GSSG remained 
unchanged (Fig. 2). So the first carcinogenesis pe-
riod was accompanied by compensatory activation 
of antioxidant cell state and there was no change 
registered in phospho-c-Jun content. The GSH con-
tent remained elevated but the GSSG was increased 
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(more than 7-fold) at 6th week of MNNG treatment. 
A decrease of GSH/GSSG on the average at 3.4-fold 
compared with reference value was revealed since 6th 
week of gastric cancer development, which proved 
the prooxidant state in the gastric mucosa cells. These 
indicators were caused by marked growth of GSSG 
content at 6th, 8th, 10th, 12th weeks and reduction of GSH 
at 8th, 12th, 18th and 24th weeks. The minimum values 
of GSH/GSSG ratio and severe prooxidant state were 
observed during 10th and 12th weeks of experimental 
gastrocarcinogenesis. These timepoints of experiment 
were characterised by the increase of phospho-c-Jun 
content but the peak of this parameter was observed 
at 6th and 8th weeks, when the GSH/GSSG ratio exceed 
the refence value at 3.8- and 3.5-fold respectively. 
Thus, there was the crucial value of intracellular redox 
state when phospho-c-Jun quantity extremely grew 
and then despite of amplification of prooxidant state 
the phospho-c-Jun content remained consistently 
high (from 12th to 24th week of gastrocarcinogenesis).
Table. The GSH/GSSG ratio in gastric mucosa cells under gastric cancer 
development
Control Observation period, week4th 6th 8th 10th 12th 18th 24th
16.1±2.6 24.4±4.3* 4.2±0.* 4.6±0.2* 1.4±0.1* 1.1±0.2* 8.2±2.0* 8.7±1.3*
Note: * the difference is significant as compared to appropriate control 
(p < 0.05).
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Fig. 2. The GSH (a) and GSSG (b) contents in gastric mucosa 
cells under gastric cancer development. *The difference is sig-
nificant as compared to appropriate control (p < 0.05)
Such marked increase in the level of phospho-c-Jun 
at the 8th week of MNNG-stimulated gastrocarcinogene-
sis accompanied with a moderate decrease of GSH and 
increase of GSSG is a probable consequence of redox 
disturbances in cell cytoplasma under ROS. It is known 
that ROS activate MAPK, but the response of distinct 
regulatory chains in different cell types is unequal. There 
are several mechanisms of MAPK activation under ROS: 
activation of redox-dependent ASK-1 as a consequence 
of thioredoxin oxidation and dissociation of JNK from 
the complex with GST Pi. Also inactivation of JNK-spe-
cific phosphatase by H2O2 may couse permanent JNK 
activation [28]. Similar activation by ROS determined 
in our study might lead to the growth of the phosphory-
lated c-Jun amount.
But if the level of oxidative stress is excessive, there 
will be a direct impact of ROS on Cys residues of DNA-
binding proteins. The oxidation of SH-groups in these 
residues results to reversible or irreversible (according 
to the ratio ROS/antioxidants) inactivation of AP-1. 
Since the promoter region of c-Jun gene has several 
zones of binding of AP-1, phosphorylation and sub-
sequent activation of factor c-Jun leads to the induc-
tion of its own gene [28]. Thus the high level of GSSG 
with the phospho-c-Jun amount decrease at the 10th 
week may indicate to acute prooxidant conditions 
that affected genome and led to an inhibition of c-Jun 
expression. In spite of this the level of phospho-c-Jun 
remained above the control values but less than at the 
previous 8th week.
The 18th and 24th weeks were characterized by the shift 
of redox-station to reduced state with the recovery 
of c-Jun expression and following its phosphorylation.
Experimental evidences support an important role 
of ROS in the cancer process. Oxidative stress can 
occur through overproduction of reactive oxygen and 
nitrogen species with the shift of GSH/GSSG ratio 
to prooxidative state. Disruption of this ratio is involved 
in several cellular reactions involved in signal transduc-
tion and cell cycle regulation under conditions of oxi-
dative stress. The unregulated or prolonged produc-
tion of cellular oxidants has been linked to mutation, 
as well as modification of gene expression. But the ef-
fects of ROS and oxidative stress within cells appear 
to be cell specific and dependent upon the form as well 
as the intercellular concentration of ROS [3]. In par-
ticular, MAPK/AP-1 signal transduction pathway, in-
cluding c-Jun activation by phosphorylation, is known 
to be activated by ROS, and leads to the transcription 
of genes involved in cell growth regulatory pathways. 
The cellular concentration of ROS appears to influ-
ence the selective activation of this transcription factor 
and therefore may help explain the observation that 
either cell death or cell proliferation may result from 
exposure to ROS. A common effect of AP-1 activation 
is an increased cell proliferation and the several lines 
of evidence have demonstrated that c-fos and c-jun 
are positive regulators of cell proliferation [9].
The acute oxidative injury may produce selective 
cell death and a compensatory increase in cell pro-
liferation. This stimulus may result in the formation 
of newly initiated preneoplastic cells and/or enhance 
the selective clonal expansion of latent initiated pre-
neoplastic cells. Similarly, sublethal acute oxidative 
injury may produce unrepaired DNA damage and result 
in the formation of new mutations and, potentially, new 
initiated cells. In contrast, sustained chronic oxidative 
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injury may lead to a nonlethal modification of normal 
cellular growth control mechanisms [3].
In conclusion, the decrease of GSH/GSSG ratio and 
simultaneously increased level of active phosphory lated 
form of c-Jun during long period (from 6th to 24th week 
of histological established progression of gastric cancer) 
point on possible MAP kinase cascade activation in prooxi-
dant conditions.
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